{"protocolSection":{"identificationModule":{"nctId":"NCT00224484","orgStudyIdInfo":{"id":"208141/040"},"organization":{"fullName":"GlaxoSmithKline","class":"INDUSTRY"},"briefTitle":"Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old","officialTitle":"A Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Herpes Simplex Candidate Vaccine (gD2-AS04) in Healthy HSV Seronegative and Seropositive Female Subjects Aged 10-17 Years."},"statusModule":{"statusVerifiedDate":"2019-01","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2004-04-07","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2007-07-24","type":"ACTUAL"},"completionDateStruct":{"date":"2007-07-24","type":"ACTUAL"},"studyFirstSubmitDate":"2005-09-21","studyFirstSubmitQcDate":"2005-09-21","studyFirstPostDateStruct":{"date":"2005-09-23","type":"ESTIMATED"},"resultsFirstSubmitDate":"2017-02-24","resultsFirstSubmitQcDate":"2017-02-24","resultsFirstPostDateStruct":{"date":"2017-04-10","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-01-03","lastUpdatePostDateStruct":{"date":"2019-01-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"GlaxoSmithKline","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"Main goal of this study is to compare the occurrence of serious adverse events (SAEs) between the herpes simplex (gD2-AS04) vaccine group and the Saline control group throughout the study period (up to month 12).\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","detailedDescription":"Three groups of females (3000, 1500 and 1500 subjects, respectively) were injected 3 times (at months 0, 1 and 6) with the herpes simplex vaccine, the HavrixTM vaccine (control) and a Saline solution (placebo), respectively. Subjects were followed over 18 months."},"conditionsModule":{"conditions":["Herpes Simplex"],"keywords":["Herpes Simplex vaccine","Safety","Adolescents","Immunogenicity"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":5960,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"GD2-AS04 GROUP","type":"EXPERIMENTAL","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","interventionNames":["Biological: GSK208141"]},{"label":"HAVRIX GROUP","type":"ACTIVE_COMPARATOR","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","interventionNames":["Biological: Havrix (investigational formulation)"]},{"label":"SALINE GROUP","type":"PLACEBO_COMPARATOR","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"GSK208141","description":"3 intramuscular doses","armGroupLabels":["GD2-AS04 GROUP"],"otherNames":["Herpes simplex vaccine","gD2-AS04 vaccine"]},{"type":"BIOLOGICAL","name":"Havrix (investigational formulation)","description":"3 intramuscular doses","armGroupLabels":["HAVRIX GROUP"]},{"type":"BIOLOGICAL","name":"Placebo","description":"3 intramuscular doses","armGroupLabels":["SALINE GROUP"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity.","timeFrame":"From Month 0 to Month 12"}],"secondaryOutcomes":[{"measure":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of any local symptom regardless of intensity grade. Grade 3 pain = pain that prevented normal activities. Grade 3 redness/swelling = greater than (\\>) 30mm diameter and persisting more than 24 hours.","timeFrame":"Within 7 days (Days 0-6) after each and any vaccination"},{"measure":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were arthralgia, fatigue, headache, malaise, rash, temperature \\[defined as oral temperature equal to or above (≥) 37.5 degrees Celsius (°C)\\] and urticaria. Any = occurrence of any general symptom regardless of intensity grade or relation to vaccination. Grade 3 arthralgia, fatigue, headache, malaise, rash = general symptom that prevented normal activity. Grade 3 temperature = greater than 39 degrees Celsius (°C). Grade 3 urticaria = urticaria distributed on at least 4 body areas. Related = general symptom assessed by the investigator as causally related to the study vaccination.","timeFrame":"Within 7 days (Days 0-6) after each and any vaccination"},{"measure":"Number of Subjects With Any, Grade 3 and Related Unsolicited Adverse Events (AEs)","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 = event which prevented normal, everyday activities. In adults/ adolescents, such an AE would, for example, prevent attendance at work/ school and would necessitate the administration of corrective therapy. Related = event assessed by the investigator as causally related to study vaccination.","timeFrame":"Within 30 days (Day 0-29) after any vaccination"},{"measure":"Number of Subjects With Unsolicited Adverse Events (AEs) With Medically Attended Visits","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. A medically attended visit is an event which prompted the subject to seek medical advice.","timeFrame":"Within the 30 Day (Day 0-29) post-vaccination period"},{"measure":"Number of Subjects With New Onset Chronic Diseases (NOCD)","description":"NOCDs include autoimmune disorders, asthma, type I diabetes, allergies.","timeFrame":"During the active phase (up to Month 12)"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents ALT results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents CREA results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents Hct results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents PLA results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents RBC results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents UREA results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents WBC results.","timeFrame":"At months 7 and 12"},{"measure":"Number of Subjects With Unsolicited Adverse Events (AEs) With Medically Attended Visits","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. A medically attended visit is an event which prompted the subject to seek medical advice.","timeFrame":"Starting from Day 30 until the end of study (Month 18)"},{"measure":"Number of Subjects With Medically Significant Conditions (MSC)","description":"MSCs include AEs prompting emergency room or physician visits that are not related to common diseases or routine visits for physical examination or vaccination, or serious adverse events (SAEs) that are not related to common diseases. Common diseases include upper respiratory infections, sinusitis, pharyngitis, gastroenteritis, urinary tract infections, cervico-vaginal yeast infections, menstrual cycle abnormalities and injury. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","timeFrame":"During the Extended Safety Follow Up (ESFU) period (Month 12 to Month 18)"},{"measure":"Number of Subjects With New Onset Chronic Diseases (NOCD)","description":"NOCDs include autoimmune disorders, asthma, type I diabetes, allergies. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","timeFrame":"During the Extended Safety Follow Up (ESFU) period (Month 12 to Month 18)"},{"measure":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","timeFrame":"Up to month 18 (during active phase and ESFU period)"},{"measure":"Anti-glycoprotein D (Anti-gD) Antibody Concentrations","description":"Concentrations are presented as geometric mean concentrations (GMCs), expressed in ELISA units per millilitre (EU/mL). Analysis was based on an immunogenicity subset, stratified by initial serostatus: HSV seronegative (-)/ seropositive (+), this included gD2-AS04 vaccine recipients, as follows: HSV 1 and HSV 2 seronegative (HSV1-/2-) and HSV 1 seropositive and HSV 2 seronegative (HSV1+/2-)","timeFrame":"At months 0, 7 and 12"},{"measure":"Anti-deacylated Monophosphoryl Lipid A (Anti-MPL) Antibody Concentrations","description":"Concentrations are presented as geometric mean concentrations (GMCs), expressed in ELISA units per millilitre (EU/mL). The subset of subjects used for this analysis was 50% of the pre-defined subset of subjects that underwent assessment of biochemical and hematological parameters.","timeFrame":"At months 0, 7 and 12"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who the investigator believes that can and will comply with the requirements of the protocol should be enrolled in the study.\n* Healthy female between, and including, 10 and 17 years of age at the time of the first vaccination.\n* Written informed assent obtained from the subject and written informed consent obtained from a parent or legal guardian of the subject prior to enrolment. If the subject is above the legal age of consent in her country, written informed consent will only be obtained from the subject.\n* Subjects must have a negative urine pregnancy test.\n* Subjects of childbearing potential at the time of study entry must be abstinent or must be using an effective method of birth control for 30 days prior to vaccination and must agree to continue such precautions for two months after completion of the vaccination series. Subjects who reach menarche during the study and therefore are of childbearing potential must agree to follow the same precautions.\n\nExclusion Criteria:\n\n* Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period.\n* Pregnant or lactating female.\n* Female planning to become pregnant or likely to become pregnant during the first eight months of the study (months 0-8).\n* Any previous confirmed history of, or current clinical signs or symptoms of, oro labial herpes (cold sores), herpetic whitlow or genital herpes disease, such as swelling, papules, vesicles, pustules, ulcers, crusts, fissures, erythema, discharge, dysuria or pain, burning, itching, tingling in the ano-genital area.\n* History of previous or planned vaccination against hepatitis A or a history of hepatitis A infection.\n* Previous vaccination against herpes.\n* History of herpetic keratitis.\n* History of multiform erythema.\n* Planned administration/administration of a vaccine not foreseen by the study protocol within 30 days before and 30 days after the first dose of study vaccine with the following exceptions: administration of routine meningococcal, hepatitis B, inactivated influenza, diphtheria/tetanus and/or diphtheria/tetanus-containing vaccine up to 8 days before and 30 days after the first dose of study vaccine.\n* History of allergic disease or reactions likely to be exacerbated by any component of the study vaccines\n* Any confirmed or suspected immunosuppressive or immunodeficient condition based on medical history and physical examination\n* History of a current acute or chronic autoimmune disease.\n* History of any neurological disorders or seizures, with the exception of a single febrile seizure during childhood.\n* Acute or chronic, clinically significant pulmonary, cardiovascular, hepatic or renal functional abnormality\n* Acute disease at the time of enrolment\n* Oral temperature \\>= 37.5°C (99.5°F) / axillary temperature \\>= 37.5°C (99.5°F) at the time of enrolment.\n* Chronic administration (defined as more than 14 days) of immunosuppressants or other immune-modifying drugs within six months prior to the first vaccine dose.\n* Administration of immunoglobulins and/or any blood products within the three months preceding the first dose of study vaccine or planned administration during the study period.","healthyVolunteers":true,"sex":"FEMALE","minimumAge":"10 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"contactsLocationsModule":{"overallOfficials":[{"name":"GSK Clinical Trials","affiliation":"GlaxoSmithKline","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"GSK Investigational Site","city":"Birmingham","state":"Alabama","zip":"35209","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"GSK Investigational Site","city":"Birmingham","state":"Alabama","zip":"35233","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"GSK Investigational Site","city":"Chandler","state":"Arizona","zip":"85224","country":"United States","geoPoint":{"lat":33.30616,"lon":-111.84125}},{"facility":"GSK Investigational Site","city":"Mesa","state":"Arizona","zip":"85201","country":"United States","geoPoint":{"lat":33.42227,"lon":-111.82264}},{"facility":"GSK Investigational Site","city":"Mesa","state":"Arizona","zip":"85213","country":"United States","geoPoint":{"lat":33.42227,"lon":-111.82264}},{"facility":"GSK Investigational Site","city":"Tempe","state":"Arizona","zip":"85282","country":"United States","geoPoint":{"lat":33.41477,"lon":-111.90931}},{"facility":"GSK Investigational Site","city":"Tucson","state":"Arizona","zip":"85710","country":"United States","geoPoint":{"lat":32.22174,"lon":-110.92648}},{"facility":"GSK Investigational Site","city":"Beverly Hills","state":"California","zip":"90211","country":"United States","geoPoint":{"lat":34.07362,"lon":-118.40036}},{"facility":"GSK Investigational Site","city":"Fountain Valley","state":"California","zip":"92708","country":"United States","geoPoint":{"lat":33.70918,"lon":-117.95367}},{"facility":"GSK Investigational Site","city":"Long Beach","state":"California","zip":"90806","country":"United States","geoPoint":{"lat":33.76696,"lon":-118.18923}},{"facility":"GSK Investigational Site","city":"Rolling Hills Estates","state":"California","zip":"90274","country":"United States","geoPoint":{"lat":33.78779,"lon":-118.35813}},{"facility":"GSK Investigational Site","city":"Centennial","state":"Colorado","zip":"80112","country":"United States","geoPoint":{"lat":39.57916,"lon":-104.87692}},{"facility":"GSK Investigational Site","city":"Littleton","state":"Colorado","zip":"80234","country":"United States","geoPoint":{"lat":39.61332,"lon":-105.01665}},{"facility":"GSK Investigational Site","city":"Thornton","state":"Colorado","zip":"80233","country":"United States","geoPoint":{"lat":39.86804,"lon":-104.97192}},{"facility":"GSK Investigational Site","city":"Westminster","state":"Colorado","zip":"80234","country":"United States","geoPoint":{"lat":39.83665,"lon":-105.0372}},{"facility":"GSK Investigational Site","city":"Wheat Ridge","state":"Colorado","zip":"80033","country":"United States","geoPoint":{"lat":39.7661,"lon":-105.07721}},{"facility":"GSK Investigational Site","city":"Norwich","state":"Connecticut","zip":"06360","country":"United States","geoPoint":{"lat":41.52426,"lon":-72.07591}},{"facility":"GSK Investigational Site","city":"Clearwater","state":"Florida","zip":"33759","country":"United States","geoPoint":{"lat":27.96585,"lon":-82.8001}},{"facility":"GSK Investigational Site","city":"Cocoa Beach","state":"Florida","zip":"32931","country":"United States","geoPoint":{"lat":28.32055,"lon":-80.60922}},{"facility":"GSK Investigational Site","city":"Melbourne","state":"Florida","zip":"332901","country":"United States","geoPoint":{"lat":28.08363,"lon":-80.60811}},{"facility":"GSK Investigational Site","city":"Naples","state":"Florida","zip":"34102","country":"United States","geoPoint":{"lat":26.14234,"lon":-81.79596}},{"facility":"GSK Investigational Site","city":"Chicago","state":"Illinois","zip":"60614","country":"United States","geoPoint":{"lat":41.85003,"lon":-87.65005}},{"facility":"GSK Investigational Site","city":"Arkansas City","state":"Kansas","zip":"67005","country":"United States","geoPoint":{"lat":37.06197,"lon":-97.03837}},{"facility":"GSK Investigational Site","city":"Wichita","state":"Kansas","zip":"67207","country":"United States","geoPoint":{"lat":37.69224,"lon":-97.33754}},{"facility":"GSK Investigational Site","city":"Towson","state":"Maryland","zip":"21286","country":"United States","geoPoint":{"lat":39.4015,"lon":-76.60191}},{"facility":"GSK Investigational Site","city":"Fridley","state":"Minnesota","zip":"55432","country":"United States","geoPoint":{"lat":45.08608,"lon":-93.26328}},{"facility":"GSK Investigational Site","city":"St Louis","state":"Missouri","zip":"63104","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"GSK Investigational Site","city":"St Louis","state":"Missouri","zip":"63141","country":"United States","geoPoint":{"lat":38.62727,"lon":-90.19789}},{"facility":"GSK Investigational Site","city":"Whitehouse Station","state":"New Jersey","zip":"08889","country":"United States","geoPoint":{"lat":40.61538,"lon":-74.77044}},{"facility":"GSK Investigational Site","city":"Albuquerque","state":"New Mexico","zip":"87102","country":"United States","geoPoint":{"lat":35.08449,"lon":-106.65114}},{"facility":"GSK Investigational Site","city":"Stony Brook","state":"New York","zip":"11794-8480","country":"United States","geoPoint":{"lat":40.92565,"lon":-73.14094}},{"facility":"GSK Investigational Site","city":"The Bronx","state":"New York","zip":"10461","country":"United States","geoPoint":{"lat":40.84985,"lon":-73.86641}},{"facility":"GSK Investigational Site","city":"The Bronx","state":"New York","zip":"10467-2490","country":"United States","geoPoint":{"lat":40.84985,"lon":-73.86641}},{"facility":"GSK Investigational Site","city":"Raleigh","state":"North Carolina","zip":"27609","country":"United States","geoPoint":{"lat":35.7721,"lon":-78.63861}},{"facility":"GSK Investigational Site","city":"Sylva","state":"North Carolina","zip":"28779","country":"United States","geoPoint":{"lat":35.37371,"lon":-83.22598}},{"facility":"GSK Investigational Site","city":"Winston-Salem","state":"North Carolina","zip":"27103","country":"United States","geoPoint":{"lat":36.09986,"lon":-80.24422}},{"facility":"GSK Investigational Site","city":"Akron","state":"Ohio","zip":"44308-1062","country":"United States","geoPoint":{"lat":41.08144,"lon":-81.51901}},{"facility":"GSK Investigational Site","city":"Cincinnati","state":"Ohio","zip":"45229","country":"United States","geoPoint":{"lat":39.12711,"lon":-84.51439}},{"facility":"GSK Investigational Site","city":"Cleveland","state":"Ohio","zip":"44121","country":"United States","geoPoint":{"lat":41.4995,"lon":-81.69541}},{"facility":"GSK Investigational Site","city":"Columbus","state":"Ohio","zip":"43214","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"GSK Investigational Site","city":"Columbus","state":"Ohio","zip":"43235","country":"United States","geoPoint":{"lat":39.96118,"lon":-82.99879}},{"facility":"GSK Investigational Site","city":"Hilliard","state":"Ohio","zip":"43026","country":"United States","geoPoint":{"lat":40.0334,"lon":-83.15825}},{"facility":"GSK Investigational Site","city":"Pickerington","state":"Ohio","zip":"43147","country":"United States","geoPoint":{"lat":39.88423,"lon":-82.7535}},{"facility":"GSK Investigational Site","city":"Westerville","state":"Ohio","zip":"43082","country":"United States","geoPoint":{"lat":40.12617,"lon":-82.92907}},{"facility":"GSK Investigational Site","city":"Portland","state":"Oregon","zip":"97216","country":"United States","geoPoint":{"lat":45.52345,"lon":-122.67621}},{"facility":"GSK Investigational Site","city":"Beaver","state":"Pennsylvania","zip":"15009","country":"United States","geoPoint":{"lat":40.69534,"lon":-80.30478}},{"facility":"GSK Investigational Site","city":"Erie","state":"Pennsylvania","zip":"16505","country":"United States","geoPoint":{"lat":42.12922,"lon":-80.08506}},{"facility":"GSK Investigational Site","city":"Erie","state":"Pennsylvania","zip":"16508","country":"United States","geoPoint":{"lat":42.12922,"lon":-80.08506}},{"facility":"GSK Investigational Site","city":"Pittsburgh","state":"Pennsylvania","zip":"15227","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"GSK Investigational Site","city":"Pittsburgh","state":"Pennsylvania","zip":"15241","country":"United States","geoPoint":{"lat":40.44062,"lon":-79.99589}},{"facility":"GSK Investigational Site","city":"Gray","state":"Tennessee","zip":"37615","country":"United States","geoPoint":{"lat":36.41983,"lon":-82.47654}},{"facility":"GSK Investigational Site","city":"Kingsport","state":"Tennessee","zip":"37660","country":"United States","geoPoint":{"lat":36.54843,"lon":-82.56182}},{"facility":"GSK Investigational Site","city":"Austin","state":"Texas","zip":"78752","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"GSK Investigational Site","city":"Beaumont","state":"Texas","zip":"77701","country":"United States","geoPoint":{"lat":30.08605,"lon":-94.10185}},{"facility":"GSK Investigational Site","city":"Galveston","state":"Texas","zip":"77555-0188","country":"United States","geoPoint":{"lat":29.30135,"lon":-94.7977}},{"facility":"GSK Investigational Site","city":"Lake Jackson","state":"Texas","zip":"77566","country":"United States","geoPoint":{"lat":29.03386,"lon":-95.43439}},{"facility":"GSK Investigational Site","city":"San Antonio","state":"Texas","zip":"78229","country":"United States","geoPoint":{"lat":29.42412,"lon":-98.49363}},{"facility":"GSK Investigational Site","city":"Temple","state":"Texas","zip":"76508","country":"United States","geoPoint":{"lat":31.09823,"lon":-97.34278}},{"facility":"GSK Investigational Site","city":"Magna","state":"Utah","zip":"84044","country":"United States","geoPoint":{"lat":40.70911,"lon":-112.10161}},{"facility":"GSK Investigational Site","city":"Salt Lake City","state":"Utah","zip":"84109","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"GSK Investigational Site","city":"Salt Lake City","state":"Utah","zip":"84121","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}},{"facility":"GSK Investigational Site","city":"Sandy City","state":"Utah","zip":"84070","country":"United States","geoPoint":{"lat":40.59161,"lon":-111.8841}},{"facility":"GSK Investigational Site","city":"West Jordan","state":"Utah","zip":"84084","country":"United States","geoPoint":{"lat":40.60967,"lon":-111.9391}},{"facility":"GSK Investigational Site","city":"West Jordan","state":"Utah","zip":"84088","country":"United States","geoPoint":{"lat":40.60967,"lon":-111.9391}},{"facility":"GSK Investigational Site","city":"Norfolk","state":"Virginia","zip":"23510","country":"United States","geoPoint":{"lat":36.84681,"lon":-76.28522}},{"facility":"GSK Investigational Site","city":"Marshfield","state":"Wisconsin","zip":"54449","country":"United States","geoPoint":{"lat":44.66885,"lon":-90.1718}},{"facility":"GSK Investigational Site","city":"Garran","state":"Australian Capital Territory","zip":"2606","country":"Australia","geoPoint":{"lat":-35.34206,"lon":149.10846}},{"facility":"GSK Investigational Site","city":"Westmead","state":"New South Wales","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"GSK Investigational Site","city":"South Brisbane","state":"Queensland","zip":"4101","country":"Australia","geoPoint":{"lat":-27.48034,"lon":153.02049}},{"facility":"GSK Investigational Site","city":"Hobart","state":"Tasmania","country":"Australia","geoPoint":{"lat":-42.87936,"lon":147.32941}},{"facility":"GSK Investigational Site","city":"Carlton","state":"Victoria","zip":"3053","country":"Australia","geoPoint":{"lat":-37.8,"lon":144.96667}},{"facility":"GSK Investigational Site","city":"Ghent","zip":"9000","country":"Belgium","geoPoint":{"lat":51.05,"lon":3.71667}},{"facility":"GSK Investigational Site","city":"Wilrijk","zip":"2610","country":"Belgium","geoPoint":{"lat":51.16734,"lon":4.39513}},{"facility":"GSK Investigational Site","city":"Edmonton","state":"Alberta","zip":"T6G 2C8","country":"Canada","geoPoint":{"lat":53.55014,"lon":-113.46871}},{"facility":"GSK Investigational Site","city":"Surrey","state":"British Columbia","zip":"V3R 8P8","country":"Canada","geoPoint":{"lat":49.10635,"lon":-122.82509}},{"facility":"GSK Investigational Site","city":"Vancouver","state":"British Columbia","zip":"V6H 3N1","country":"Canada","geoPoint":{"lat":49.24966,"lon":-123.11934}},{"facility":"GSK Investigational Site","city":"Ottawa","state":"Ontario","zip":"K1S 0G8","country":"Canada","geoPoint":{"lat":45.41117,"lon":-75.69812}},{"facility":"GSK Investigational Site","city":"Beauport","state":"Quebec","zip":"G1E 7G9","country":"Canada","geoPoint":{"lat":46.85884,"lon":-71.19201}},{"facility":"GSK Investigational Site","city":"Sainte-Foy","state":"Quebec","zip":"G1V 4G2","country":"Canada","geoPoint":{"lat":46.78139,"lon":-71.29217}},{"facility":"GSK Investigational Site","city":"Aarhus N","zip":"8200","country":"Denmark","geoPoint":{"lat":56.20367,"lon":10.17317}},{"facility":"GSK Investigational Site","city":"Tallinn","zip":"10617","country":"Estonia","geoPoint":{"lat":59.43696,"lon":24.75353}},{"facility":"GSK Investigational Site","city":"Tartu","zip":"50417","country":"Estonia","geoPoint":{"lat":58.38062,"lon":26.72509}},{"facility":"GSK Investigational Site","city":"Château-Renault","zip":"37110","country":"France","geoPoint":{"lat":47.59188,"lon":0.91143}},{"facility":"GSK Investigational Site","city":"Derval","zip":"44590","country":"France","geoPoint":{"lat":47.66772,"lon":-1.67176}},{"facility":"GSK Investigational Site","city":"Évreux","zip":"27000","country":"France","geoPoint":{"lat":49.02414,"lon":1.15082}},{"facility":"GSK Investigational Site","city":"Haute-Goulaine","zip":"44115","country":"France","geoPoint":{"lat":47.19904,"lon":-1.43012}},{"facility":"GSK Investigational Site","city":"La Chapelle-sur-Erdre","zip":"44240","country":"France","geoPoint":{"lat":47.29964,"lon":-1.55239}},{"facility":"GSK Investigational Site","city":"Le Temple-de-Bretagne","zip":"44360","country":"France","geoPoint":{"lat":47.32868,"lon":-1.79143}},{"facility":"GSK Investigational Site","city":"Luynes","zip":"37230","country":"France","geoPoint":{"lat":47.38441,"lon":0.5547}},{"facility":"GSK Investigational Site","city":"Nantes","zip":"44000","country":"France","geoPoint":{"lat":47.21725,"lon":-1.55336}},{"facility":"GSK Investigational Site","city":"Nantes","zip":"44300","country":"France","geoPoint":{"lat":47.21725,"lon":-1.55336}},{"facility":"GSK Investigational Site","city":"Nort-sur-Erdre","zip":"44390","country":"France","geoPoint":{"lat":47.4399,"lon":-1.49909}},{"facility":"GSK Investigational Site","city":"Paris","zip":"75015","country":"France","geoPoint":{"lat":48.85341,"lon":2.3488}},{"facility":"GSK Investigational Site","city":"Pont-de-l'Arche","zip":"27340","country":"France","geoPoint":{"lat":49.30324,"lon":1.15481}},{"facility":"GSK Investigational Site","city":"Saint-Aubin-des-Châteaux","zip":"44110","country":"France","geoPoint":{"lat":47.72024,"lon":-1.48654}},{"facility":"GSK Investigational Site","city":"Saint-Avertin","zip":"37550","country":"France","geoPoint":{"lat":47.36357,"lon":0.73993}},{"facility":"GSK Investigational Site","city":"Saint-Sébastien-sur-Loire","zip":"44230","country":"France","geoPoint":{"lat":47.20768,"lon":-1.50332}},{"facility":"GSK Investigational Site","city":"Tours","zip":"37000","country":"France","geoPoint":{"lat":47.39484,"lon":0.70398}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11527","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Athens","zip":"11528","country":"Greece","geoPoint":{"lat":37.98376,"lon":23.72784}},{"facility":"GSK Investigational Site","city":"Komotini","zip":"69100","country":"Greece","geoPoint":{"lat":41.11758,"lon":25.40587}},{"facility":"GSK Investigational Site","city":"Thessaloniki","zip":"54636","country":"Greece","geoPoint":{"lat":40.64072,"lon":22.93493}},{"facility":"GSK Investigational Site","city":"Bordány","zip":"6795","country":"Hungary","geoPoint":{"lat":46.31843,"lon":19.92306}},{"facility":"GSK Investigational Site","city":"Budapest","zip":"1089","country":"Hungary","geoPoint":{"lat":47.49835,"lon":19.04045}},{"facility":"GSK Investigational Site","city":"Győr","zip":"9024","country":"Hungary","geoPoint":{"lat":47.68333,"lon":17.63512}},{"facility":"GSK Investigational Site","city":"Hódmezővásárhely","zip":"6800","country":"Hungary","geoPoint":{"lat":46.41667,"lon":20.33333}},{"facility":"GSK Investigational Site","city":"Szeged","zip":"6720","country":"Hungary","geoPoint":{"lat":46.253,"lon":20.14824}},{"facility":"GSK Investigational Site","city":"Szeged","zip":"6723","country":"Hungary","geoPoint":{"lat":46.253,"lon":20.14824}},{"facility":"GSK Investigational Site","city":"Zsombó","zip":"6792","country":"Hungary","geoPoint":{"lat":46.32566,"lon":19.97464}},{"facility":"GSK Investigational Site","city":"Garðabaer","zip":"210","country":"Iceland","geoPoint":{"lat":64.08865,"lon":-21.92298}},{"facility":"GSK Investigational Site","city":"Kopavogur","country":"Iceland","geoPoint":{"lat":64.11234,"lon":-21.91298}},{"facility":"GSK Investigational Site","city":"Reykjavik","zip":"112","country":"Iceland","geoPoint":{"lat":64.13548,"lon":-21.89541}},{"facility":"GSK Investigational Site","city":"Kaunas","zip":"LT-47144","country":"Lithuania","geoPoint":{"lat":54.90156,"lon":23.90909}},{"facility":"GSK Investigational Site","city":"Panevezys","zip":"LT-37355","country":"Lithuania","geoPoint":{"lat":55.73186,"lon":24.35983}},{"facility":"GSK Investigational Site","city":"Vilnius","zip":"LT-01205","country":"Lithuania","geoPoint":{"lat":54.68916,"lon":25.2798}},{"facility":"GSK Investigational Site","city":"Vilnius","zip":"LT-02169","country":"Lithuania","geoPoint":{"lat":54.68916,"lon":25.2798}},{"facility":"GSK Investigational Site","city":"Vilnius","zip":"LT-07156","country":"Lithuania","geoPoint":{"lat":54.68916,"lon":25.2798}},{"facility":"GSK Investigational Site","city":"Rotterdam","zip":"3011 EN","country":"Netherlands","geoPoint":{"lat":51.9225,"lon":4.47917}},{"facility":"GSK Investigational Site","city":"Christchurch","zip":"8001","country":"New Zealand","geoPoint":{"lat":-43.53333,"lon":172.63333}},{"facility":"GSK Investigational Site","city":"Bergen","zip":"N-5021","country":"Norway","geoPoint":{"lat":60.39299,"lon":5.32415}},{"facility":"GSK Investigational Site","city":"Oslo","zip":"N-0159","country":"Norway","geoPoint":{"lat":59.91273,"lon":10.74609}},{"facility":"GSK Investigational Site","city":"Bucharest","zip":"020125","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"GSK Investigational Site","city":"Bucharest","zip":"077190","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"GSK Investigational Site","city":"Bucharest","country":"Romania","geoPoint":{"lat":44.43225,"lon":26.10626}},{"facility":"GSK Investigational Site","city":"Blanes","country":"Spain","geoPoint":{"lat":41.67419,"lon":2.79036}},{"facility":"GSK Investigational Site","city":"Castellon","country":"Spain","geoPoint":{"lat":39.98567,"lon":-0.04935}},{"facility":"GSK Investigational Site","city":"Madrid","zip":"28009","country":"Spain","geoPoint":{"lat":40.4165,"lon":-3.70256}},{"facility":"GSK Investigational Site","city":"Montgat/Barcelona","zip":"08390","country":"Spain"},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46017","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46021","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46023","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Valencia","zip":"46024","country":"Spain","geoPoint":{"lat":39.47391,"lon":-0.37966}},{"facility":"GSK Investigational Site","city":"Gothenburg","zip":"SE-416 85","country":"Sweden","geoPoint":{"lat":57.70716,"lon":11.96679}},{"facility":"GSK Investigational Site","city":"Karlskrona","zip":"SE-371 41","country":"Sweden","geoPoint":{"lat":56.16156,"lon":15.58661}},{"facility":"GSK Investigational Site","city":"Linköping","zip":"SE-581 85","country":"Sweden","geoPoint":{"lat":58.41086,"lon":15.62157}},{"facility":"GSK Investigational Site","city":"Malmö","zip":"SE-205 02","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"GSK Investigational Site","city":"Örebro","zip":"SE-702 11","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}},{"facility":"GSK Investigational Site","city":"Umeå","zip":"SE-901 85","country":"Sweden","geoPoint":{"lat":63.82842,"lon":20.25972}},{"facility":"GSK Investigational Site","city":"Southampton","state":"Hampshire","zip":"SO14 0YG","country":"United Kingdom","geoPoint":{"lat":50.90395,"lon":-1.40428}},{"facility":"GSK Investigational Site","city":"Blackpool","state":"Lancashire","zip":"FY2 9RS","country":"United Kingdom","geoPoint":{"lat":53.81667,"lon":-3.05}},{"facility":"GSK Investigational Site","city":"Blackpool","state":"Lancashire","zip":"FY3 7DG","country":"United Kingdom","geoPoint":{"lat":53.81667,"lon":-3.05}},{"facility":"GSK Investigational Site","city":"Blackpool","state":"Lancashire","zip":"FY4 3AD","country":"United Kingdom","geoPoint":{"lat":53.81667,"lon":-3.05}},{"facility":"GSK Investigational Site","city":"Bolton","state":"Lancashire","zip":"BL4 9QZ","country":"United Kingdom","geoPoint":{"lat":53.58333,"lon":-2.43333}},{"facility":"GSK Investigational Site","city":"Coventry","state":"Warwickshire","zip":"CV5 6EU","country":"United Kingdom","geoPoint":{"lat":52.40656,"lon":-1.51217}},{"facility":"GSK Investigational Site","city":"Coventry","state":"Warwickshire","zip":"CV6 4DD","country":"United Kingdom","geoPoint":{"lat":52.40656,"lon":-1.51217}},{"facility":"GSK Investigational Site","city":"Coventry","state":"West Midlands","zip":"CV2 1AX","country":"United Kingdom","geoPoint":{"lat":52.40656,"lon":-1.51217}},{"facility":"GSK Investigational Site","city":"Bradford","zip":"BD5 0JD","country":"United Kingdom","geoPoint":{"lat":53.79391,"lon":-1.75206}},{"facility":"GSK Investigational Site","city":"Doncaster","zip":"DN1 2EG","country":"United Kingdom","geoPoint":{"lat":53.52285,"lon":-1.13116}},{"facility":"GSK Investigational Site","city":"Leeds","zip":"LS12 1JE","country":"United Kingdom","geoPoint":{"lat":53.79648,"lon":-1.54785}},{"facility":"GSK Investigational Site","city":"London","zip":"SW10 9TH","country":"United Kingdom","geoPoint":{"lat":51.50853,"lon":-0.12574}},{"facility":"GSK Investigational Site","city":"Sheffield","zip":"S10 2JF","country":"United Kingdom","geoPoint":{"lat":53.38297,"lon":-1.4659}}]},"referencesModule":{"references":[{"pmid":"23313657","type":"BACKGROUND","citation":"Tavares F, Cheuvart B, Heineman T, Arellano F, Dubin G. Meta-analysis of pregnancy outcomes in pooled randomized trials on a prophylactic adjuvanted glycoprotein D subunit herpes simplex virus vaccine. Vaccine. 2013 Mar 25;31(13):1759-64. doi: 10.1016/j.vaccine.2013.01.002. Epub 2013 Jan 10."},{"pmid":"23850416","type":"BACKGROUND","citation":"HSV-040 Study Group; Abu-Elyazeed RR, Heineman T, Dubin G, Fourneau M, Leroux-Roels I, Leroux-Roels G, Richardus JH, Ostergaard L, Diez-Domingo J, Poder A, Van Damme P, Romanowski B, Blatter M, Silfverdal SA, Berglund J, Josefsson A, Cunningham AL, Flodmark CE, Tragiannidis A, Dobson S, Olafsson J, Puig-Barbera J, Mendez M, Barton S, Bernstein D, Mares J, Ratner P. Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial. Vaccine. 2013 Dec 9;31(51):6136-43. doi: 10.1016/j.vaccine.2013.06.081. Epub 2013 Jul 9."},{"pmid":"18845199","type":"BACKGROUND","citation":"Verstraeten T, Descamps D, David MP, Zahaf T, Hardt K, Izurieta P, Dubin G, Breuer T. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine. 2008 Dec 2;26(51):6630-8. doi: 10.1016/j.vaccine.2008.09.049."}],"seeAlsoLinks":[{"label":"Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.","url":"https://www.clinicalstudydatarequest.com"}],"availIpds":[{"id":"208141/040","type":"Dataset Specification","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"208141/040","type":"Clinical Study Report","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"208141/040","type":"Study Protocol","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"208141/040","type":"Statistical Analysis Plan","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"208141/040","type":"Individual Participant Data Set","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"},{"id":"208141/040","type":"Informed Consent Form","url":"https://www.clinicalstudydatarequest.com","comment":"For additional information about this study please refer to the GSK Clinical Study Register"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site."}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"FG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"FG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","comment":"5960 subjects were randomized, but only 5955 received vaccination","achievements":[{"groupId":"FG000","numSubjects":"2977"},{"groupId":"FG001","numSubjects":"1491"},{"groupId":"FG002","numSubjects":"1487"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"2831"},{"groupId":"FG001","numSubjects":"1426"},{"groupId":"FG002","numSubjects":"1425"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"146"},{"groupId":"FG001","numSubjects":"65"},{"groupId":"FG002","numSubjects":"62"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Non-Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"7"},{"groupId":"FG002","numSubjects":"3"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"49"},{"groupId":"FG001","numSubjects":"18"},{"groupId":"FG002","numSubjects":"16"}]},{"type":"Migrated/moved from study area","reasons":[{"groupId":"FG000","numSubjects":"18"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"5"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"66"},{"groupId":"FG001","numSubjects":"28"},{"groupId":"FG002","numSubjects":"36"}]},{"type":"Reason not specified","reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"2"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"BG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"BG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"BG003","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"2977"},{"groupId":"BG001","value":"1491"},{"groupId":"BG002","value":"1487"},{"groupId":"BG003","value":"5955"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"13.81","spread":"2.21"},{"groupId":"BG001","value":"13.81","spread":"2.21"},{"groupId":"BG002","value":"13.83","spread":"2.21"},{"groupId":"BG003","value":"13.81","spread":"2.21"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"2977"},{"groupId":"BG001","value":"1491"},{"groupId":"BG002","value":"1487"},{"groupId":"BG003","value":"5955"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"White/Caucasian","categories":[{"measurements":[{"groupId":"BG000","value":"2650"},{"groupId":"BG001","value":"1340"},{"groupId":"BG002","value":"1330"},{"groupId":"BG003","value":"5320"}]}]},{"title":"Arabic/North African","categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"33"}]}]},{"title":"East/South East Asian","categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"32"}]}]},{"title":"South Asian","categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"14"}]}]},{"title":"American Hispanic","categories":[{"measurements":[{"groupId":"BG000","value":"78"},{"groupId":"BG001","value":"27"},{"groupId":"BG002","value":"34"},{"groupId":"BG003","value":"139"}]}]},{"title":"Not specified","categories":[{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"31"},{"groupId":"BG003","value":"111"}]}]},{"title":"Black","categories":[{"measurements":[{"groupId":"BG000","value":"157"},{"groupId":"BG001","value":"78"},{"groupId":"BG002","value":"71"},{"groupId":"BG003","value":"306"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"From Month 0 to Month 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1487"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"71"},{"groupId":"OG001","value":"42"},{"groupId":"OG002","value":"37"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any and Grade 3 Solicited Local Symptoms","description":"Assessed solicited local symptoms were pain, redness and swelling. Any = occurrence of any local symptom regardless of intensity grade. Grade 3 pain = pain that prevented normal activities. Grade 3 redness/swelling = greater than (\\>) 30mm diameter and persisting more than 24 hours.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, only on subjects with their symptom sheets completed, who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days (Days 0-6) after each and any vaccination","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"classes":[{"title":"Pain, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2120"},{"groupId":"OG001","value":"508"},{"groupId":"OG002","value":"247"}]}]},{"title":"Pain, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"106"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"6"}]}]},{"title":"Redness, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"598"},{"groupId":"OG001","value":"125"},{"groupId":"OG002","value":"103"}]}]},{"title":"Redness, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"464"},{"groupId":"OG001","value":"66"},{"groupId":"OG002","value":"50"}]}]},{"title":"Swelling, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"5"}]}]},{"title":"Pain, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1685"},{"groupId":"OG001","value":"389"},{"groupId":"OG002","value":"189"}]}]},{"title":"Pain, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"90"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"4"}]}]},{"title":"Redness, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"582"},{"groupId":"OG001","value":"95"},{"groupId":"OG002","value":"70"}]}]},{"title":"Redness, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"Swelling, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"499"},{"groupId":"OG001","value":"38"},{"groupId":"OG002","value":"31"}]}]},{"title":"Swelling, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1463"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"Pain, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1729"},{"groupId":"OG001","value":"377"},{"groupId":"OG002","value":"161"}]}]},{"title":"Pain, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"137"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"2"}]}]},{"title":"Redness, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"567"},{"groupId":"OG001","value":"80"},{"groupId":"OG002","value":"62"}]}]},{"title":"Redness, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Swelling, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"540"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"32"}]}]},{"title":"Swelling, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"Pain, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2529"},{"groupId":"OG001","value":"787"},{"groupId":"OG002","value":"407"}]}]},{"title":"Pain, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"278"},{"groupId":"OG001","value":"26"},{"groupId":"OG002","value":"12"}]}]},{"title":"Redness, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1120"},{"groupId":"OG001","value":"222"},{"groupId":"OG002","value":"174"}]}]},{"title":"Redness, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"107"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"Swelling, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"979"},{"groupId":"OG001","value":"125"},{"groupId":"OG002","value":"90"}]}]},{"title":"Swelling, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"7"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Solicited General Symptoms","description":"Assessed solicited general symptoms were arthralgia, fatigue, headache, malaise, rash, temperature \\[defined as oral temperature equal to or above (≥) 37.5 degrees Celsius (°C)\\] and urticaria. Any = occurrence of any general symptom regardless of intensity grade or relation to vaccination. Grade 3 arthralgia, fatigue, headache, malaise, rash = general symptom that prevented normal activity. Grade 3 temperature = greater than 39 degrees Celsius (°C). Grade 3 urticaria = urticaria distributed on at least 4 body areas. Related = general symptom assessed by the investigator as causally related to the study vaccination.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, only on subjects with their symptom sheets completed, who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 7 days (Days 0-6) after each and any vaccination","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"classes":[{"title":"Arthralgia, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"375"},{"groupId":"OG001","value":"141"},{"groupId":"OG002","value":"122"}]}]},{"title":"Arthralgia, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"281"},{"groupId":"OG001","value":"103"},{"groupId":"OG002","value":"83"}]}]},{"title":"Arthralgia, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}]},{"title":"Fatigue, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"864"},{"groupId":"OG001","value":"377"},{"groupId":"OG002","value":"384"}]}]},{"title":"Fatigue, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"246"},{"groupId":"OG002","value":"247"}]}]},{"title":"Fatigue, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"51"},{"groupId":"OG001","value":"24"},{"groupId":"OG002","value":"17"}]}]},{"title":"Headache, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"836"},{"groupId":"OG001","value":"379"},{"groupId":"OG002","value":"395"}]}]},{"title":"Headache, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"232"},{"groupId":"OG002","value":"239"}]}]},{"title":"Headache, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"47"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"15"}]}]},{"title":"Malaise, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"515"},{"groupId":"OG001","value":"213"},{"groupId":"OG002","value":"225"}]}]},{"title":"Malaise, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"354"},{"groupId":"OG001","value":"138"},{"groupId":"OG002","value":"146"}]}]},{"title":"Malaise, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"13"}]}]},{"title":"Rash, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"23"}]}]},{"title":"Rash, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"11"}]}]},{"title":"Rash, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"Temperature (Orally), Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"122"},{"groupId":"OG001","value":"59"},{"groupId":"OG002","value":"63"}]}]},{"title":"Temperature(Orally), Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"31"}]}]},{"title":"Temperature(Orally), Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"}]}]},{"title":"Urticaria, Any, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"16"}]}]},{"title":"Urticaria, Related, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"10"}]}]},{"title":"Urticaria, Grade 3, Dose 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2966"},{"groupId":"OG001","value":"1490"},{"groupId":"OG002","value":"1482"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"4"}]}]},{"title":"Arthralgia, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"259"},{"groupId":"OG001","value":"102"},{"groupId":"OG002","value":"54"}]}]},{"title":"Arthralgia, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"219"},{"groupId":"OG001","value":"77"},{"groupId":"OG002","value":"39"}]}]},{"title":"Arthralgia, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"2"}]}]},{"title":"Fatigue, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"566"},{"groupId":"OG001","value":"226"},{"groupId":"OG002","value":"233"}]}]},{"title":"Fatigue, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"427"},{"groupId":"OG001","value":"157"},{"groupId":"OG002","value":"163"}]}]},{"title":"Fatigue, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"8"}]}]},{"title":"Headache, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"245"}]}]},{"title":"Headache, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"387"},{"groupId":"OG001","value":"192"},{"groupId":"OG002","value":"157"}]}]},{"title":"Headache, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"7"}]}]},{"title":"Malaise, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"340"},{"groupId":"OG001","value":"151"},{"groupId":"OG002","value":"124"}]}]},{"title":"Malaise, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"240"},{"groupId":"OG001","value":"103"},{"groupId":"OG002","value":"88"}]}]},{"title":"Malaise, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"7"}]}]},{"title":"Rash, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"20"}]}]},{"title":"Rash, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"17"}]}]},{"title":"Rash, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Temperature(Orally), Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"126"},{"groupId":"OG001","value":"58"},{"groupId":"OG002","value":"55"}]}]},{"title":"Temperature(Orally), Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"63"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"27"}]}]},{"title":"Temperature(Orally), Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Urticaria, Any, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]}]},{"title":"Urticaria, Related, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"7"}]}]},{"title":"Urticaria, Grade 3, Dose 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2911"},{"groupId":"OG001","value":"1466"},{"groupId":"OG002","value":"1465"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Arthralgia, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"239"},{"groupId":"OG001","value":"77"},{"groupId":"OG002","value":"64"}]}]},{"title":"Arthralgia, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"210"},{"groupId":"OG001","value":"56"},{"groupId":"OG002","value":"50"}]}]},{"title":"Arthralgia, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"Fatigue, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"539"},{"groupId":"OG001","value":"213"},{"groupId":"OG002","value":"201"}]}]},{"title":"Fatigue, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"429"},{"groupId":"OG001","value":"158"},{"groupId":"OG002","value":"143"}]}]},{"title":"Fatigue, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}]},{"title":"Headache, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"513"},{"groupId":"OG001","value":"224"},{"groupId":"OG002","value":"199"}]}]},{"title":"Headache, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"376"},{"groupId":"OG001","value":"155"},{"groupId":"OG002","value":"123"}]}]},{"title":"Headache, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"16"}]}]},{"title":"Malaise, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"321"},{"groupId":"OG001","value":"112"},{"groupId":"OG002","value":"118"}]}]},{"title":"Malaise, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"248"},{"groupId":"OG001","value":"77"},{"groupId":"OG002","value":"81"}]}]},{"title":"Malaise, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"39"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"15"}]}]},{"title":"Rash, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"14"}]}]},{"title":"Rash, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"9"}]}]},{"title":"Rash, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Temperature (Orally), Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"163"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"69"}]}]},{"title":"Temperature(Orally), Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"84"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"25"}]}]},{"title":"Temperature(Orally), Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]},{"title":"Urticaria, Any, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"6"}]}]},{"title":"Urticaria, Related, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"5"}]}]},{"title":"Urticaria, Grade 3, Dose 3","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2852"},{"groupId":"OG001","value":"1430"},{"groupId":"OG002","value":"1435"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"Arthralgia, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"585"},{"groupId":"OG001","value":"233"},{"groupId":"OG002","value":"192"}]}]},{"title":"Arthralgia, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"482"},{"groupId":"OG001","value":"183"},{"groupId":"OG002","value":"139"}]}]},{"title":"Arthralgia, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"9"}]}]},{"title":"Fatigue, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1176"},{"groupId":"OG001","value":"524"},{"groupId":"OG002","value":"526"}]}]},{"title":"Fatigue, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"913"},{"groupId":"OG001","value":"382"},{"groupId":"OG002","value":"376"}]}]},{"title":"Fatigue, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"113"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"38"}]}]},{"title":"Headache, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1240"},{"groupId":"OG001","value":"579"},{"groupId":"OG002","value":"549"}]}]},{"title":"Headache, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"875"},{"groupId":"OG001","value":"408"},{"groupId":"OG002","value":"364"}]}]},{"title":"Headache, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"113"},{"groupId":"OG001","value":"47"},{"groupId":"OG002","value":"34"}]}]},{"title":"Malaise, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"834"},{"groupId":"OG001","value":"362"},{"groupId":"OG002","value":"347"}]}]},{"title":"Malaise, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"253"},{"groupId":"OG002","value":"237"}]}]},{"title":"Malaise, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"118"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"31"}]}]},{"title":"Rash, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"141"},{"groupId":"OG001","value":"46"},{"groupId":"OG002","value":"51"}]}]},{"title":"Rash, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"93"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"35"}]}]},{"title":"Rash, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Temperature (Orally), Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"360"},{"groupId":"OG001","value":"158"},{"groupId":"OG002","value":"167"}]}]},{"title":"Temperature (Orally), Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"193"},{"groupId":"OG001","value":"65"},{"groupId":"OG002","value":"77"}]}]},{"title":"Temperature (Orally), Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"}]}]},{"title":"Urticaria, Any, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"50"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"27"}]}]},{"title":"Urticaria, Related, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"21"}]}]},{"title":"Urticaria, Grade 3, Across doses","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2970"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1484"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"5"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Any, Grade 3 and Related Unsolicited Adverse Events (AEs)","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. Any was defined as the occurrence of any unsolicited AE regardless of intensity grade or relation to vaccination. Grade 3 = event which prevented normal, everyday activities. In adults/ adolescents, such an AE would, for example, prevent attendance at work/ school and would necessitate the administration of corrective therapy. Related = event assessed by the investigator as causally related to study vaccination.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within 30 days (Day 0-29) after any vaccination","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1487"}]}],"classes":[{"title":"Any AEs","categories":[{"measurements":[{"groupId":"OG000","value":"1325"},{"groupId":"OG001","value":"676"},{"groupId":"OG002","value":"667"}]}]},{"title":"Grade 3 AEs","categories":[{"measurements":[{"groupId":"OG000","value":"154"},{"groupId":"OG001","value":"68"},{"groupId":"OG002","value":"83"}]}]},{"title":"Related AEs","categories":[{"measurements":[{"groupId":"OG000","value":"313"},{"groupId":"OG001","value":"136"},{"groupId":"OG002","value":"128"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Unsolicited Adverse Events (AEs) With Medically Attended Visits","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. A medically attended visit is an event which prompted the subject to seek medical advice.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Within the 30 Day (Day 0-29) post-vaccination period","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1487"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"585"},{"groupId":"OG001","value":"297"},{"groupId":"OG002","value":"298"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With New Onset Chronic Diseases (NOCD)","description":"NOCDs include autoimmune disorders, asthma, type I diabetes, allergies.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the active phase (up to Month 12)","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1487"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents ALT results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"273"}]}],"classes":[{"title":"ALT, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"253"},{"groupId":"OG002","value":"273"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"519"},{"groupId":"OG001","value":"249"},{"groupId":"OG002","value":"268"}]}]},{"title":"ALT, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"253"},{"groupId":"OG002","value":"273"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"253"},{"groupId":"OG002","value":"273"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"}]}]},{"title":"ALT, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"530"},{"groupId":"OG001","value":"253"},{"groupId":"OG002","value":"273"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"529"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"267"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"514"},{"groupId":"OG001","value":"246"},{"groupId":"OG002","value":"259"}]}]},{"title":"ALT, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"529"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"267"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"529"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"267"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"}]}]},{"title":"ALT, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"529"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"267"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]},{"title":"ALT, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"ALT, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE BELOW, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"ALT, PRE ABOVE, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"ALT, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"}]}]},{"title":"ALT, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"ALT, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}]},{"title":"ALT, PRE ABOVE, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"7"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents CREA results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"586"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"300"}]}],"classes":[{"title":"CREA, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"586"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"300"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"543"},{"groupId":"OG001","value":"268"},{"groupId":"OG002","value":"284"}]}]},{"title":"CREA, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"586"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"300"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"}]}]},{"title":"CREA, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"586"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"300"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"9"}]}]},{"title":"CREA, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"586"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"300"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"CREA, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"583"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"551"},{"groupId":"OG001","value":"257"},{"groupId":"OG002","value":"275"}]}]},{"title":"CREA, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"583"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"}]}]},{"title":"CREA, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"583"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"10"}]}]},{"title":"CREA, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"583"},{"groupId":"OG001","value":"282"},{"groupId":"OG002","value":"292"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"1"}]}]},{"title":"CREA, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}]},{"title":"CREA, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"10"}]}]},{"title":"CREA, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"CREA, PRE BELOW, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"43"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"2"}]}]},{"title":"CREA, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"6"}]}]},{"title":"CREA, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"8"}]}]},{"title":"CREA, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"22"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"CREA, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"11"}]}]},{"title":"CREA, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"CREA, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"16"},{"groupId":"OG002","value":"12"}]}]},{"title":"CREA, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"7"}]}]},{"title":"CREA, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"CREA, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"15"}]}]},{"title":"CREA, PRE ABOVE, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"23"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents Hct results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"311"}]}],"classes":[{"title":"Hct, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"311"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"562"},{"groupId":"OG001","value":"279"},{"groupId":"OG002","value":"287"}]}]},{"title":"Hct, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"311"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"15"}]}]},{"title":"Hct, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"311"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Hct, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"611"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"311"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"}]}]},{"title":"Hct, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"303"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"562"},{"groupId":"OG001","value":"275"},{"groupId":"OG002","value":"276"}]}]},{"title":"Hct, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"303"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"17"}]}]},{"title":"Hct, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"303"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"}]}]},{"title":"Hct, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"295"},{"groupId":"OG002","value":"303"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"}]}]},{"title":"Hct, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"}]}]},{"title":"Hct, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"}]}]},{"title":"Hct, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hct, PRE BELOW, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hct, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"}]}]},{"title":"Hct, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"}]}]},{"title":"Hct, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hct, PRE BELOW, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hct, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"8"}]}]},{"title":"Hct, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hct, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"Hct, PRE ABOVE, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"10"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hct, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}]},{"title":"Hct, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hct, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"Hct, PRE ABOVE, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents PLA results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"296"},{"groupId":"OG002","value":"307"}]}],"classes":[{"title":"PLA, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"307"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"576"},{"groupId":"OG001","value":"286"},{"groupId":"OG002","value":"292"}]}]},{"title":"PLA, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"307"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"}]}]},{"title":"PLA, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"307"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"5"}]}]},{"title":"PLA, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"608"},{"groupId":"OG001","value":"294"},{"groupId":"OG002","value":"307"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"}]}]},{"title":"PLA, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"296"},{"groupId":"OG002","value":"299"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"278"},{"groupId":"OG002","value":"284"}]}]},{"title":"PLA, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"296"},{"groupId":"OG002","value":"299"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"296"},{"groupId":"OG002","value":"299"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"5"}]}]},{"title":"PLA, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"296"},{"groupId":"OG002","value":"299"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"10"}]}]},{"title":"PLA, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"PLA, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"PLA, PRE BELOW, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"PLA, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"}]}]},{"title":"PLA, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"PLA, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE BELOW, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"14"}]}]},{"title":"PLA, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"11"}]}]},{"title":"PLA, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"18"}]}]},{"title":"PLA, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"PLA, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"6"}]}]},{"title":"PLA, PRE ABOVE, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"36"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"25"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents RBC results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"300"},{"groupId":"OG002","value":"312"}]}],"classes":[{"title":"RBC, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"298"},{"groupId":"OG002","value":"312"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"580"},{"groupId":"OG001","value":"284"},{"groupId":"OG002","value":"295"}]}]},{"title":"RBC, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"298"},{"groupId":"OG002","value":"312"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"8"}]}]},{"title":"RBC, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"298"},{"groupId":"OG002","value":"312"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"RBC, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"607"},{"groupId":"OG001","value":"298"},{"groupId":"OG002","value":"312"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"300"},{"groupId":"OG002","value":"305"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"574"},{"groupId":"OG001","value":"281"},{"groupId":"OG002","value":"280"}]}]},{"title":"RBC, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"300"},{"groupId":"OG002","value":"305"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}]},{"title":"RBC, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"300"},{"groupId":"OG002","value":"305"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"9"}]}]},{"title":"RBC, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"603"},{"groupId":"OG001","value":"300"},{"groupId":"OG002","value":"305"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"6"}]}]},{"title":"RBC, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"RBC, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"}]}]},{"title":"RBC, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"21"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"13"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"RBC, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"RBC, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"4"}]}]},{"title":"RBC, PRE ABOVE, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"11"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"}]}]},{"title":"RBC, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"7"}]}]},{"title":"RBC, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"RBC, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"RBC, PRE ABOVE, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"26"},{"groupId":"OG001","value":"8"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents UREA results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"651"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"329"}]}],"classes":[{"title":"UREA, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"651"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"329"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"632"},{"groupId":"OG001","value":"304"},{"groupId":"OG002","value":"316"}]}]},{"title":"UREA, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"651"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"329"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"9"}]}]},{"title":"UREA, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"651"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"329"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"UREA, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"651"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"329"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"}]}]},{"title":"UREA, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"643"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"320"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"615"},{"groupId":"OG001","value":"301"},{"groupId":"OG002","value":"304"}]}]},{"title":"UREA, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"643"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"320"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"10"}]}]},{"title":"UREA, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"643"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"320"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"}]}]},{"title":"UREA, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"643"},{"groupId":"OG001","value":"310"},{"groupId":"OG002","value":"320"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"}]}]},{"title":"UREA, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"7"}]}]},{"title":"UREA, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"}]}]},{"title":"UREA, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"8"}]}]},{"title":"UREA, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"1"}]}]},{"title":"UREA, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE BELOW, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"9"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]},{"title":"UREA, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"UREA, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"1"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Reporting Clinically Relevant Abnormalities in Biochemical and Haematological Laboratory Parameters Assessed","description":"Assessed parameters were alanine aminotransferase (ALT), creatinine (CREA), haematocrit (Hct), platelets (PLA), red blood cells (RBC), urea and white blood cells (WBC). A subset of subjects was formed for these analyses. Subjects were categorized according to their results at pre-vaccination at Month 0 (PRE) which were normal, above normal or below the normal range. Per parameter and range, it was assessed whether laboratory values of the subjects were normal, above normal or below the normal range at other timepoints. This outcome presents WBC results.","populationDescription":"The analyses were performed on a subset of subjects from the Total Vaccinated cohort, which included subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"At months 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"286"}]}],"classes":[{"title":"WBC, PRE NORMAL, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"271"},{"groupId":"OG002","value":"286"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"534"},{"groupId":"OG001","value":"243"},{"groupId":"OG002","value":"253"}]}]},{"title":"WBC, PRE NORMAL, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"271"},{"groupId":"OG002","value":"286"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"23"},{"groupId":"OG002","value":"17"}]}]},{"title":"WBC, PRE NORMAL, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"271"},{"groupId":"OG002","value":"286"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"9"}]}]},{"title":"WBC, PRE NORMAL, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"579"},{"groupId":"OG001","value":"271"},{"groupId":"OG002","value":"286"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"7"}]}]},{"title":"WBC, PRE NORMAL, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"577"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"282"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"525"},{"groupId":"OG001","value":"247"},{"groupId":"OG002","value":"251"}]}]},{"title":"WBC, PRE NORMAL, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"577"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"282"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"17"}]}]},{"title":"WBC, PRE NORMAL, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"577"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"282"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"9"}]}]},{"title":"WBC, PRE NORMAL, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"577"},{"groupId":"OG001","value":"274"},{"groupId":"OG002","value":"282"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"5"}]}]},{"title":"WBC, PRE BELOW, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"36"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"40"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"19"}]}]},{"title":"WBC, PRE BELOW, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"36"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"17"}]}]},{"title":"WBC, PRE BELOW, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"36"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, PRE BELOW, M7- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"64"},{"groupId":"OG001","value":"35"},{"groupId":"OG002","value":"36"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, PRE BELOW, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"31"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"41"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"16"}]}]},{"title":"WBC, PRE BELOW, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"31"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"12"}]}]},{"title":"WBC, PRE BELOW, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"31"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"}]}]},{"title":"WBC, PRE BELOW, M12- MISSING","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"31"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"}]}]},{"title":"WBC, PRE ABOVE, M7- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"10"}]}]},{"title":"WBC, PRE ABOVE, M7- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, PRE ABOVE, M7- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"5"},{"groupId":"OG002","value":"4"}]}]},{"title":"WBC, PRE ABOVE, M12- NORMAL","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"11"}]}]},{"title":"WBC, PRE ABOVE, M12- BELOW","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}]}]},{"title":"WBC, PRE ABOVE, M12- ABOVE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"12"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"14"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"3"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Unsolicited Adverse Events (AEs) With Medically Attended Visits","description":"An unsolicited AE covers any untoward medical occurrence in a clinical investigation subject temporally associated with the use of a medicinal product, whether or not considered related to the medicinal product and reported in addition to those solicited during the clinical study and any solicited symptom with onset outside the specified period of follow-up for solicited symptoms. A medically attended visit is an event which prompted the subject to seek medical advice.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Starting from Day 30 until the end of study (Month 18)","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"1491"},{"groupId":"OG002","value":"1487"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"397"},{"groupId":"OG001","value":"201"},{"groupId":"OG002","value":"188"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Medically Significant Conditions (MSC)","description":"MSCs include AEs prompting emergency room or physician visits that are not related to common diseases or routine visits for physical examination or vaccination, or serious adverse events (SAEs) that are not related to common diseases. Common diseases include upper respiratory infections, sinusitis, pharyngitis, gastroenteritis, urinary tract infections, cervico-vaginal yeast infections, menstrual cycle abnormalities and injury. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available. For the purpose of this analysis, the subjects from Havrix Group and Saline group were pooled into one group: Pooled Group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the Extended Safety Follow Up (ESFU) period (Month 12 to Month 18)","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Pooled Group","description":"Pooled group of subjects 10-17 years of age from Havrix and Saline groups."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"2978"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"73"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With New Onset Chronic Diseases (NOCD)","description":"NOCDs include autoimmune disorders, asthma, type I diabetes, allergies. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available. For the purpose of this analysis, the subjects from Havrix Group and Saline group were pooled into one group: Pooled Group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"During the Extended Safety Follow Up (ESFU) period (Month 12 to Month 18)","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Pooled Group","description":"Pooled group of subjects 10-17 years of age from Havrix and Saline groups."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"2978"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Subjects With Serious Adverse Events (SAEs)","description":"Serious adverse events (SAEs) assessed include medical occurrences that result in death, are life threatening, require hospitalization or prolongation of hospitalization or result in disability/incapacity. For outcomes covering the ESFU period, the Havrix Group and Saline Group were pooled.","populationDescription":"The analyses were performed on the Total Vaccinated cohort, which included all subjects who received at least one dose of the study vaccine and for whom data were available. For the purpose of this analysis, the subjects from Havrix Group and Saline group were pooled into one group: Pooled Group.","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Up to month 18 (during active phase and ESFU period)","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Pooled Group","description":"Pooled group of subjects 10-17 years of age from Havrix and Saline groups."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"2977"},{"groupId":"OG001","value":"2978"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"90"},{"groupId":"OG001","value":"100"}]}]}]},{"type":"SECONDARY","title":"Anti-glycoprotein D (Anti-gD) Antibody Concentrations","description":"Concentrations are presented as geometric mean concentrations (GMCs), expressed in ELISA units per millilitre (EU/mL). Analysis was based on an immunogenicity subset, stratified by initial serostatus: HSV seronegative (-)/ seropositive (+), this included gD2-AS04 vaccine recipients, as follows: HSV 1 and HSV 2 seronegative (HSV1-/2-) and HSV 1 seropositive and HSV 2 seronegative (HSV1+/2-)","populationDescription":"The analysis was performed on the ATP cohort for immunogenicity, in a predefined immunogenicity subset of HSV vaccine recipients (gD2-AS04 Group) who underwent assessment of biochemical and hematological parameters. Data from participants in the \"Havrix Group\" and \"Saline Group\" were not collected.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At months 0, 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"386"}]}],"classes":[{"title":"HSV1-2-, PRE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"338"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23.0","lowerLimit":"21.7","upperLimit":"24.4"}]}]},{"title":"HSV1-2-, M7","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"386"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"7808.6","lowerLimit":"7185.3","upperLimit":"8485.9"}]}]},{"title":"HSV1-2-, M12","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"380"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2408.9","lowerLimit":"2200.8","upperLimit":"2636.7"}]}]},{"title":"HSV1+2-, PRE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"190"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1702.1","lowerLimit":"1440.6","upperLimit":"2011.0"}]}]},{"title":"HSV1+2-, M7","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"179"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"10344.1","lowerLimit":"9552.2","upperLimit":"11201.5"}]}]},{"title":"HSV1+2-, M12","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"170"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"6411.8","lowerLimit":"5820.8","upperLimit":"7062.9"}]}]}]},{"type":"SECONDARY","title":"Anti-deacylated Monophosphoryl Lipid A (Anti-MPL) Antibody Concentrations","description":"Concentrations are presented as geometric mean concentrations (GMCs), expressed in ELISA units per millilitre (EU/mL). The subset of subjects used for this analysis was 50% of the pre-defined subset of subjects that underwent assessment of biochemical and hematological parameters.","populationDescription":"The analyses were performed on the According-To-Protocol cohort for immunogenicity, which included all evaluable subjects included in the immunogenicity subset for whom data concerning immunogenicity outcome measures were available (for whom assay results were available for antibodies against the study vaccine antigen component after Vaccination).","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"EU/mL","timeFrame":"At months 0, 7 and 12","groups":[{"id":"OG000","title":"gD2-AS04 Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG001","title":"Havrix Group","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."},{"id":"OG002","title":"Saline Group","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"303"},{"groupId":"OG001","value":"128"},{"groupId":"OG002","value":"151"}]}],"classes":[{"title":"Anti-MPL, PRE","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"288"},{"groupId":"OG001","value":"119"},{"groupId":"OG002","value":"140"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"195.2","lowerLimit":"172.6","upperLimit":"220.8"},{"groupId":"OG001","value":"168.3","lowerLimit":"138.3","upperLimit":"204.7"},{"groupId":"OG002","value":"198.4","lowerLimit":"166.4","upperLimit":"236.5"}]}]},{"title":"Anti-MPL, M7","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"303"},{"groupId":"OG001","value":"128"},{"groupId":"OG002","value":"151"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"801.9","lowerLimit":"722.7","upperLimit":"889.7"},{"groupId":"OG001","value":"152.7","lowerLimit":"125.6","upperLimit":"185.6"},{"groupId":"OG002","value":"190.7","lowerLimit":"159.7","upperLimit":"227.7"}]}]},{"title":"Anti-MPL, M12","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"298"},{"groupId":"OG001","value":"127"},{"groupId":"OG002","value":"150"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"537.4","lowerLimit":"488.9","upperLimit":"590.8"},{"groupId":"OG001","value":"193.8","lowerLimit":"161.2","upperLimit":"233.0"},{"groupId":"OG002","value":"232.9","lowerLimit":"198.3","upperLimit":"273.5"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Serious Adverse Events: -Group GD2-AS04, Group Havrix and Group Saline: during the active study period (Month 0 - 12). -GD2-AS04 (ESFU) Group and Pooled Group: during the combined active study period and the ESFU period (Month 0 - 18). Other Adverse Events: -Solicited local/general symptoms: during the 7-day post-vaccination period. -Unsolicited Adverse Events: during the 30-day post-vaccination.","description":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.\n\nOther Adverse Events were not collected during the ESFU period, hence resulting in zero participants at risk for GD2-AS04 (ESFU) Group and Pooled Group.","eventGroups":[{"id":"EG000","title":"Group GD2-AS04","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","deathsNumAffected":0,"deathsNumAtRisk":2977,"seriousNumAffected":71,"seriousNumAtRisk":2977,"otherNumAffected":2718,"otherNumAtRisk":2977},{"id":"EG001","title":"Group Havrix","description":"Female subjects aged 10-17 years, who received 3 doses of Havrix™ vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","deathsNumAffected":0,"deathsNumAtRisk":1491,"seriousNumAffected":42,"seriousNumAtRisk":1491,"otherNumAffected":1210,"otherNumAtRisk":1491},{"id":"EG002","title":"Group Saline","description":"Female subjects aged 10-17 years, who received 3 doses of a saline solution, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","deathsNumAffected":0,"deathsNumAtRisk":1487,"seriousNumAffected":37,"seriousNumAtRisk":1487,"otherNumAffected":1082,"otherNumAtRisk":1487},{"id":"EG003","title":"GD2-AS04 (ESFU) Group","description":"Female subjects aged 10-17 years, who received 3 doses of gD2-AS04 vaccine, which were administered intramuscularly in the deltoid region of the non-dominant arm according to a 0, 1, 6 months schedule.","deathsNumAffected":0,"deathsNumAtRisk":2977,"seriousNumAffected":90,"seriousNumAtRisk":2977,"otherNumAffected":0,"otherNumAtRisk":0},{"id":"EG004","title":"Pooled Group","description":"Pooled group of subjects 10-17 years of age from Havrix and Saline groups, included in the Extended Safety Follow Up (ESFU) period.","deathsNumAffected":0,"deathsNumAtRisk":2978,"seriousNumAffected":100,"seriousNumAtRisk":2978,"otherNumAffected":0,"otherNumAtRisk":0}],"seriousEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Lymphadenitis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Sinus bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Hyperthyroidism","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Maculopathy","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Abdominal pain lower","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Gastritis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Lip swelling","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Peritonitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Cyst","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Granuloma","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Hypothermia","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Hypersensitivity","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Acute tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":2977},{"groupId":"EG001","numAffected":3,"numAtRisk":1491},{"groupId":"EG002","numAffected":3,"numAtRisk":1487},{"groupId":"EG003","numAffected":11,"numAtRisk":2977},{"groupId":"EG004","numAffected":8,"numAtRisk":2978}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Carbuncle","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Chronic tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Folliculitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Gastroenteritis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Herpes zoster","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Infectious mononucleosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":3,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Meningitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Peritonsillar abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Pharyngotonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":2,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Pilonidal cyst","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Salpingitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":2,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":3,"numAtRisk":2978}]},{"term":"Tonsillitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":3,"numAtRisk":2978}]},{"term":"Tracheobronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Viral upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Animal bite","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Carbon monoxide poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Cervical vertebral fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Clavicle fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Concussion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":3,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Hand fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Jaw fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Joint dislocation","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Joint injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Ligament rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Lower limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Patella fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Poisoning","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Spinal compression fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Anorexia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Dehydration","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Arthralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Ovarian adenoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Convulsion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Dyskinesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Facial paresis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Migraine","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":2,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Neuropathy peripheral","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Painful response to normal stimuli","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Peripheral nerve lesion","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Abortion spontaneous","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":2,"numAtRisk":1491},{"groupId":"EG002","numAffected":4,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":7,"numAtRisk":2978}]},{"term":"Abortion spontaneous incomplete","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Abnormal behaviour","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Agression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Alcohol abuse","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Anorexia nervosa","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Bipolar disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":2,"numAtRisk":1487},{"groupId":"EG003","numAffected":8,"numAtRisk":2977},{"groupId":"EG004","numAffected":5,"numAtRisk":2978}]},{"term":"Drug abuse","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":2,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Hallucination","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Intentional self-injury","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Mental disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Psychotic disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Schizophrenia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Suicidal ideation","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Suicide attempt","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":5,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Nephrotic syndrome","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Dysmenorrhoea","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Haemorrhagic ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":1,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Ovarian cyst","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Ovarian cyst ruptured","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Hyperventilation","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":2,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Hypoxia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Pneumomediastinum","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Pneumothorax","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Alopecia","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":2977},{"groupId":"EG001","numAffected":1,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Abdominal discomfort","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Cystitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Encephalitis viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Fusarium infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Gastroenteritis rotavirus","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Incision site infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Meningitis aseptic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Pyelonephritis acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Salmonellosis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Meniscus lesion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Therapeutic agent toxicity","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Vertebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Wound","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":2,"numAtRisk":2978}]},{"term":"Brain oedema","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Paraparesis","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Syncope vasovagal","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Abortion spontaneous complete","organSystem":"Pregnancy, puerperium and perinatal conditions","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Anxiety disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Conversion disorder","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":1,"numAtRisk":2977},{"groupId":"EG004","numAffected":0,"numAtRisk":2978}]},{"term":"Endometriosis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Gastrointestinal disorder","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]},{"term":"Acute sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":2977},{"groupId":"EG001","numAffected":0,"numAtRisk":1491},{"groupId":"EG002","numAffected":0,"numAtRisk":1487},{"groupId":"EG003","numAffected":0,"numAtRisk":2977},{"groupId":"EG004","numAffected":1,"numAtRisk":2978}]}],"otherEvents":[{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":147,"numAtRisk":2977},{"groupId":"EG001","numAffected":75,"numAtRisk":1491},{"groupId":"EG002","numAffected":81,"numAtRisk":1487},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":151,"numAtRisk":2977},{"groupId":"EG001","numAffected":50,"numAtRisk":1491},{"groupId":"EG002","numAffected":69,"numAtRisk":1487},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Pain","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":2529,"numAtRisk":2970},{"groupId":"EG001","numAffected":787,"numAtRisk":1491},{"groupId":"EG002","numAffected":407,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Redness","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":1120,"numAtRisk":2970},{"groupId":"EG001","numAffected":222,"numAtRisk":1491},{"groupId":"EG002","numAffected":174,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":979,"numAtRisk":2970},{"groupId":"EG001","numAffected":125,"numAtRisk":1491},{"groupId":"EG002","numAffected":90,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Arthralgia","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":585,"numAtRisk":2970},{"groupId":"EG001","numAffected":233,"numAtRisk":1491},{"groupId":"EG002","numAffected":192,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":1176,"numAtRisk":2970},{"groupId":"EG001","numAffected":524,"numAtRisk":1491},{"groupId":"EG002","numAffected":526,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Headache","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":1240,"numAtRisk":2970},{"groupId":"EG001","numAffected":579,"numAtRisk":1491},{"groupId":"EG002","numAffected":549,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":834,"numAtRisk":2970},{"groupId":"EG001","numAffected":362,"numAtRisk":1491},{"groupId":"EG002","numAffected":347,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]},{"term":"Temperature (Orally)","organSystem":"General disorders","sourceVocabulary":"MedDRA 11.0","assessmentType":"SYSTEMATIC_ASSESSMENT","notes":"The solicited local and general symptoms were only collected for those subjects who filled in their symptom sheets.","stats":[{"groupId":"EG000","numAffected":360,"numAtRisk":2970},{"groupId":"EG001","numAffected":158,"numAtRisk":1491},{"groupId":"EG002","numAffected":167,"numAtRisk":1484},{"groupId":"EG003","numAtRisk":0},{"groupId":"EG004","numAtRisk":0}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"GSK Response Center","organization":"GlaxoSmithKline","phone":"866-435-7343"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D006561","term":"Herpes Simplex"}],"ancestors":[{"id":"D006566","term":"Herpesviridae Infections"},{"id":"D004266","term":"DNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D007239","term":"Infections"},{"id":"D017193","term":"Skin Diseases, Viral"},{"id":"D012874","term":"Skin Diseases, Infectious"},{"id":"D012871","term":"Skin Diseases"},{"id":"D017437","term":"Skin and Connective Tissue Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"D022301","term":"Herpes Simplex Virus Vaccines"},{"id":"D022362","term":"Hepatitis A Vaccines"}],"ancestors":[{"id":"D022283","term":"Herpesvirus Vaccines"},{"id":"D014765","term":"Viral Vaccines"},{"id":"D014612","term":"Vaccines"},{"id":"D001688","term":"Biological Products"},{"id":"D045424","term":"Complex Mixtures"},{"id":"D014761","term":"Viral Hepatitis Vaccines"}]}},"hasResults":true}